- Home
- AXGN vs CCCC Comparison
AXGN vs CCCC Comparison
Compare AXGN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- CCCC
- Stock Information
- Founded
- AXGN N/A
- CCCC 2015
- Country
- AXGN United States
- CCCC United States
- Employees
- AXGN N/A
- CCCC N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- AXGN Health Care
- CCCC Health Care
- Exchange
- AXGN Nasdaq
- CCCC Nasdaq
- Market Cap
- AXGN 584.7M
- CCCC 405.6M
- IPO Year
- AXGN N/A
- CCCC 2020
- Fundamental
- Price
- AXGN $13.15
- CCCC $6.25
- Analyst Decision
- AXGN Strong Buy
- CCCC Buy
- Analyst Count
- AXGN 4
- CCCC 6
- Target Price
- AXGN $15.00
- CCCC $10.50
- AVG Volume (30 Days)
- AXGN 370.0K
- CCCC 731.1K
- Earning Date
- AXGN 11-05-2024
- CCCC 10-30-2024
- Dividend Yield
- AXGN N/A
- CCCC N/A
- EPS Growth
- AXGN N/A
- CCCC N/A
- EPS
- AXGN N/A
- CCCC N/A
- Revenue
- AXGN $173,482,000.00
- CCCC $29,378,000.00
- Revenue This Year
- AXGN $18.49
- CCCC $39.70
- Revenue Next Year
- AXGN $12.78
- CCCC N/A
- P/E Ratio
- AXGN N/A
- CCCC N/A
- Revenue Growth
- AXGN 17.26
- CCCC 83.26
- 52 Week Low
- AXGN $3.45
- CCCC $1.06
- 52 Week High
- AXGN $15.23
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- AXGN 44.12
- CCCC 54.57
- Support Level
- AXGN $13.08
- CCCC $6.26
- Resistance Level
- AXGN $15.23
- CCCC $7.14
- Average True Range (ATR)
- AXGN 0.65
- CCCC 0.37
- MACD
- AXGN -0.17
- CCCC 0.12
- Stochastic Oscillator
- AXGN 12.97
- CCCC 58.99
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.